New heart pump could help High-Risk patients during angioplasty

NCT ID NCT07407816

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a temporary heart pump called the Supira System in 45 people with heart failure and severe coronary artery disease who need high-risk angioplasty. The pump is inserted through a leg artery to help the heart pump blood during and after the procedure. Researchers want to see if it is safe and works well enough to avoid the need for more advanced support like a balloon pump or ECMO.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Supira System (a temporary heart pump inserted through a leg artery)
What this could lead to
If successful, this could provide a new option to support the heart during and after high-risk angioplasty, potentially reducing complications in people with severe heart disease.
What could go wrong
This is a small, early feasibility study with only 45 participants, so results may not apply to everyone. The device is inserted through an artery, which carries risks like bleeding, infection, or damage to blood vessels or the heart.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CORONARY ARTERIAL DISEASE (CAD) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Israeli-Georgian Medical Research Clinic HealthyCore 13g Tevdore-Mghvdeli Street Tbilisi Georgia

    RECRUITING

    Tbilisi, Georgia

  • Tbilisi Heart and Vascular Clinic

    RECRUITING

    Tbilisi, K'alak'i T'bilisi, 0112, Georgia

More trials for these conditions

Other studies related to the condition(s) this trial covers.